Name: Q-Plex™ Mouse Cytokine Panel 1 (6-Plex)
Kit Type: Multiplex ELISA
Multiplex Format: Antibody Array
Species Reactivity: Mouse
Detection Method: Chemiluminescent
Analytes: IFN-γ, IL-1α, IL-1β, IL-6, IL-10, TNFα
|Analytes||Top Point (pg/ml)||Low Point (pg/ml)|
* Actual values may vary from kit to kit. Please see the antigen card included in your kit for specific values.
Ordering Information: Catalog # 115249MS
Toll Free: 888-QUANSYS (782-6797)
The Q-Plex Mouse Cytokine Panel 1 (6-Plex) is a fully quantitative ELISA-based chemiluminescent assay allowing concurrent measurement of six biomarkers or analytes (IFN-γ, IL-1α, IL-1β, IL-6, IL-10, TNFα).
Each kit contains a 96-well plate, with each well featuring the relevant biomarker panel, and all the reagents required to perform testing. Q-Plex plates are built by absorbing six distinct capture antibodies in a defined array to the bottom of each well. Our high quality reagents help ensure the accuracy of your results.
Using just 50 µl of sample per well, up to 80 samples can be assayed for all six markers in the panel in 2.5 hours. Q-Plex Arrays provide scientists with an easy-to-use and cost effective means of generating a cytokine profile for each sample.
Each kit contains a 96-well plate, featuring the relevant biomarker panel in each well, and all reagents required to perform testing.
- Detection mix
- Sample diluents
- Wash buffer
- Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer’s disease
Authors: Claudia Balducci, Angelisa Frasca, Margherita Zotti, et al.
Brain, Behavior, and Immunity 2017: doi.org/10.1016/j.bbi.2016.10.012
- 5-Fluorouracil chemotherapy upregulates cytokines and alters hippocampal dendritic complexity in aged mice
Authors: Thomas R. Groves, Ryan Farris, Julie E. Anderson
Behavioural Brain Research 2017: doi.org/10.1016/j.bbr.2016.08.039
- Exploration of α1-Antitrypsin Treatment Protocol for Islet Transplantation: Dosing Plan and Route of Administration
Authors: Boris M. Baranovski, Eyal Ozeri, Galit Shahaf, et al.
Journal of Pharmacology and Experimental Therapeutics 2016: https://doi.org/10.1124/ jpet.116.236067
- Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors
Authors: María Galán, Saray Varona, Mar Orriols, et al.
Disease Models & Mechanisms 2016 9: 541-552; doi: 10.1242/dmm.024513